Variable | OR (95% CI) | P value |
Model 1 | ||
Age, years (per 1 year increase) | 1.13 (1.06 to 1.21) | <0.001 |
Disease duration, years (per 1 year increase) | 0.99 (0.93 to 1.07) | 0.963 |
Smoking (pack-years) | 1.02 (0.99 to 1.05) | 0.292 |
BMI (kg/m2) (per 1 unit increase) | 1.05 (0.95 to 1.15) | 0.341 |
Antiphospholipid antibody positivity | 3.66 (1.24 to 10.80) | 0.019 |
SLICC/ACR DI (points per 1 point increase) | 1.07 (0.67 to 1.70) | 0.781 |
Presence of plaques at baseline | 0.38 (0.10 to 1.46) | 0.158 |
Glucocorticoids, cumulative dose (g) (per 1 g increase) | 1.04 (1.01 to 1.07) | 0.010 |
Statin, current use | 0.68 (0.20 to 2.32) | 0.538 |
Model 2 | ||
Age, years (per 1 year increase) | 1.10 (1.05 to 1.16) | <0.001 |
Antiphospholipid antibody positivity | 3.51 (1.25 to 9.89) | 0.017 |
Glucocorticoids, cumulative dose (g) (per 1 g increase) | 1.04 (1.01 to 1.07) | 0.011 |
Model 1 adjusted for age, disease duration, smoking, BMI, antiphospholipid antibody positivity, SLICC/ACR DI, presence of plaques at baseline, glucocorticoid cumulative dose and statin current use.
Model 2 adjusted for age, antiphospholipid antibody positivity and glucocorticoid cumulative dose.
BMI, body mass index; SLICC/ACR DI, Systemic Lupus International Collaborative Clinics/American College of Rheumatology Damage Index.